-+ 0.00%
-+ 0.00%
-+ 0.00%

The decline in Teva Pharmaceuticals stock price extended to 5.4% after the company stopped a phase II study.

Zhitongcaijing·11/02/2026 13:09:40
Listen to the news
The decline in Teva Pharmaceuticals stock price extended to 5.4% after the company stopped a phase II study.